Bhatia Sangeeta N.'s Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Aug 2, 2022
- Accession no.
- 0000899243-22-027386
- Filed
- Aug 2, 2022
- Trade date
- Jul 29, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $173.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bhatia Sangeeta N.CIK 0001643921 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock | SSaleDisposed | −99 | $276.65F2,F3 | −$27,388.35 | 5,804 | Direct | |
| Jul 29, 2022 | Common Stock | SSaleDisposed | −200 | $277.95F2,F4 | −$55,590 | 5,604 | Direct | |
| Jul 29, 2022 | Common Stock | SSaleDisposed | −160 | $279.28F2,F5 | −$44,684.8 | 5,444 | Direct | |
| Jul 29, 2022 | Common Stock | SSaleDisposed | −99 | $280.22F2,F6 | −$27,741.78 | 5,345 | Direct | |
| Jul 29, 2022 | Common Stock | SSaleDisposed | −58 | $281.03F2,F7 | −$16,299.74 | 5,287 | Direct | |
| Jul 29, 2022 | Common Stock | SSaleDisposed | −5 | $282.34 | −$1,411.7 | 5,282 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $276.65 (range $276.21 to $276.83).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $277.95 (range $277.63 to $278.35).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $279.28 (range $278.86 to $279.83).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $280.22 (range $279.88 to $280.78).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $281.03 (range $280.93 to $281.08).
Referenced by the price of 1 transaction in Table I.